Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
Journal
Orphanet journal of rare diseases
Journal Volume
17
Journal Issue
1
Pages
236
Date Issued
2022-12
Author(s)
Dispenzieri, Angela
Coelho, Teresa
Conceição, Isabel
Waddington-Cruz, Márcia
Wixner, Jonas
Kristen, Arnt V
Rapezzi, Claudio
Planté-Bordeneuve, Violaine
Gonzalez-Moreno, Juan
Maurer, Mathew S
Grogan, Martha
Chapman, Doug
Amass, Leslie
Abstract
Transthyretin amyloidosis (ATTR amyloidosis) is a rare, life-threatening disease caused by the accumulation of variant or wild-type (ATTRwt amyloidosis) transthyretin amyloid fibrils in the heart, peripheral nerves, and other tissues and organs.
Subjects
Amyloidosis; Cardiomyopathy; Polyneuropathy; Registry; Transthyretin
Type
journal article